New Drug Application News and Research

RSS
Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Combination treatment improves outcomes in advanced kidney cancer patients

Combination treatment improves outcomes in advanced kidney cancer patients

Developments in Engineered T Cells for Type 1 Diabetes

Developments in Engineered T Cells for Type 1 Diabetes